Prolonged use of puberty-delaying medicines among transgender youth linked to lower bone mineral density - News-Medical.Net

A longer duration of treatment with puberty-delaying medications among transgender youth is associated with lower bone mineral density, according to a new study that will be presented Sunday at ENDO 2022, the Endocrine Society's annual meeting in Atlanta, Ga.

A longer duration of treatment with puberty-delaying medications among transgender youth is associated with lower bone mineral density, according to a new study that will be presented Sunday at ENDO … [+2199 chars]

full article...